"The Institut Pasteur du Cambodge (IPC) is a Cambodian non-profit research institution. In 1992, the IPC was re-opened based on an agreement with the Royal Government of Cambodia (RGC) and the Institut Pasteur (IP, Paris, France) that was renewed in 2013. The IPC operates under the senior patronage of the Cambodian Ministry of Health (MoH), on behalf of which, it carries out life sciences and health research as well as public services and training activities."

During the past decade, Institut Pasteur in Cambodia, Clinical Pathology Unit conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Institut Pasteur in Cambodia, Clinical Pathology Unit" #1 collaborator was "Queensland Institute of Medical Research" with 2 trials as a collaborator, "University of Nottingham" with 2 trials as a collaborator, "World Health Organization" with 2 trials as a collaborator, "Commonwealth Scientific and Industrial Research Organisation, Australia" with 1 trials as a collaborator and "Commonwealth Scientific and Industrial Research Organisation, Division of Livestock Industries, Brisbane, Australia" with 1 trials as a collaborator. Other collaborators include 5 different institutions and companies that were collaborators in the rest 15 trials.

According to Clinical.Site data, the most researched conditions in "Institut Pasteur in Cambodia, Clinical Pathology Unit" are "Ancylostoma Caninum" (1 trials), "Ancylostoma Ceylanicum" (1 trials), "Ancylostoma Duodenal" (1 trials), "Ascaris Lumbricoides" (1 trials) and "Ascaris Suum" (1 trials). Many other conditions were trialed in "Institut Pasteur in Cambodia, Clinical Pathology Unit" in a lesser frequency.

Most popular intervention types in "Institut Pasteur in Cambodia, Clinical Pathology Unit" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Albendazole" (1 trials) and "Mebendazole" (1 trials). Other intervention names were less common.

The vast majority of trials in "Institut Pasteur in Cambodia, Clinical Pathology Unit" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Institut Pasteur in Cambodia, Clinical Pathology Unit". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Institut Pasteur in Cambodia, Clinical Pathology Unit, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Institut Pasteur in Cambodia, Clinical Pathology Unit, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".